...
首页> 外文期刊>Regulatory peptides. >Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
【24h】

Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.

机译:精氨酸加压素和血管紧张素II受体之间的相互作用在钠平衡的中央调节中。

获取原文
获取原文并翻译 | 示例

摘要

We speculated that the influence of lateral preoptic area (LPO) in sodium balance, involves arginine8-vasopressin (AVP) and angiotensin (ANG II) on Na+ uptake in LPO. Therefore, the present study investigated the effects of central administration of specific AVP and ANG II antagonists (d(CH2)5-Tyr (Me)-AVP (AAVP) and [Adamanteanacetyl1, 0-ET-d-Tyr2, Val4, Aminobutyryl6, Arg(8,9)]-AVP (ATAVP) antagonists of V1 and V2 receptors of AVP. Also the effects of losartan and CGP42112A (selective ligands of the AT1 and AT2 angiotensin receptors, respectively), was investigated on Na+ uptake and renal fluid and electrolyte excretion. After an acclimatization period of 7 days, the animals were maintained under tribromoethanol (200 mg/kg body weight, intraperitonial) anesthesia and placed in a Kopf stereotaxic instrument. Stainless guide cannula was implanted into the LPO. AAVP and ATAVP injected into the LPO prior to AVP produced a reduction in the NaCl intake. Both the AT1 and AT2 ligands administered into the LPO elicited a decrease in the NaCl intake induced by AVP injected into the LPO. AVP injection into the LPO increased sodium renal excretion, but this was reduced by prior AAVP administration. The ATAVP produced a decreased in the natriuretic effect of AVP. The losartan injected into LPO previous to AVP decreased the sodium excretion and the CGP 421122A also decreased the natriuretic effect of AVP. The AVP produced an antidiuresis effect that was inhibited by prior administration into LPO of the ATAVP. The AAVP produced no change in the antidiuretic effect of AVP. These results suggest that LPO are implicated in sodium balance that is mediated by V1, V2, AT1 and AT2 receptors.
机译:我们推测侧视前区(LPO)在钠平衡中的影响涉及精氨酸8-加压素(AVP)和血管紧张素(ANG II)对LPO中Na +吸收的影响。因此,本研究调查了特定AVP和ANG II拮抗剂(d(CH2)5-Tyr(Me)-AVP(AAVP)和[Adamanteanacetyl1,0-ET-d-Tyr2,Val4,Aminobutyryl6,研究了AVP的V1和V2受体的Arg(8,9)]-AVP(ATAVP)拮抗剂,还研究了氯沙坦和CGP42112A(分别为AT1和AT2血管紧张素受体的选择性配体)对Na +摄取和肾液的影响适应7天后,将动物维持在三溴乙醇(200 mg / kg体重,腹膜内)麻醉下并置于Kopf立体定位仪中,将不锈钢引导套管植入LPO中,分别注射AAVP和ATAVP在AVP之前注入LPO会降低NaCl的摄入量;向LPO给药的AT1和AT2配体都会引起AVP注入LPO引起的NaCl摄入的减少。这个w如先前的AAVP管理所减少。 ATAVP使AVP的利尿钠作用降低。 AVP之前在LPO中注射的氯沙坦会降低钠排泄,而CGP 421122A也会降低AVP的利钠作用。 AVP产生了抗利尿作用,该作用可通过事先向ATAVP的LPO给药来抑制。 AAVP的抗利尿作用没有改变。这些结果表明,LPO与V1,V2,AT1和AT2受体介导的钠平衡有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号